ALPINE IMMUNE SCIENCES, INC. (ALPN) has 34 open-market insider trades by 16 insiders since 2011. The most active filer is Mitchell Gold, CEO & Chairman.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Peter A. Thompson | Dir | — | 4 | $88.9M | 2024-05-18 |
| Xiangmin Cui | Dir10% Owner | — | 2 | $33.7M | 2024-01-18 |
| OrbiMed Genesis GP LLC | Dir | — | 1 | $28.7M | 2023-12-28 |
| Decheng Capital Management III (Cayman), LLC via Xiangmin Cui | 10% Owner | — | 1 | $14.5M | 2021-09-17 |
| Orbimed Advisors LLC | Dir10% Owner | — | 2 | $11.5M | 2024-05-18 |
| Mitchell Gold | CEOChairman | — | 9 | $8.1M | 2024-05-20 |
| Jay Venkatesan | Dir10% Owner | — | 2 | $5.8M | 2022-07-15 |
| James N. Topper | Dir10% Owner | — | 2 | $4.0M | 2024-05-18 |
| Frazier Life Sciences VIII, L.P. | 10% Owner | — | 1 | $2.0M | 2019-01-18 |
| FHM LIFE Sciences Viii, L.P. | Dir10% Owner | — | 1 | $1.6M | 2022-02-11 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| James N. Topper | Director | Sell | $1K | 2024-04-25 |
| James Paul Rickey | — | Sell | $4.4M | 2024-01-25 |
| Mitchell Gold | Chairman | Sell | $20K | 2023-12-28 |
| OrbiMed Genesis GP LLC | Director | Sell | $28.7M | 2023-12-27 |
| Peter A. Thompson | Director | Sell | $57.3M | 2023-12-27 |
| Mitchell Gold | CEO & Chairman | Sell | $3.7M | 2023-12-22 |
Companies that share insiders with ALPN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Mitchell Gold | Chairman | Sell | $48K | 2023-12-19 |
| James Paul Rickey | — | Sell | $584K | 2023-12-19 |
| James Paul Rickey | — | Sell | $2.0M | 2023-12-14 |
| Mitchell Gold | CEO & Chairman | Sell | $3.5M | 2023-12-08 |
| James Paul Rickey | — | Sell | $2.3M | 2023-12-04 |
| James Paul Rickey | — | Sell | $11K | 2023-11-30 |
| Xiangmin Cui | Director & 10% Owner | Buy | $4.7M | 2023-11-09 |
| James Paul Rickey | — | Sell | $577K | 2023-11-06 |
| FHM LIFE Sciences Viii, L.P. | Director & 10% Owner | Buy | $1.6M | 2022-02-11 |